BIOMAT Database Logo BIOMAT Database Logo

[CHANGES IN PLASMA INSULIN-LIKE ACTIVITY AFTER GLUCOSE LOADING IN DIABETICS]. 1964

K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO
Insulin kinetics in juvenile canine diabetics after glucose loading.
April 1983, American journal of veterinary research,
K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO
INSULIN-LIKE ACTIVITY IN PANCREATIC VEIN BLOOD AFTER GLUCOSE LOADING AND EPINEPHRINE HYPERGLYCEMIA.
July 1964, Endocrinology,
K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO
Plasma insulin activity in diabetics.
May 1959, Postgraduate medical journal,
K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO
Plasma-insulin after tolbutamide in diabetics and non-diabetics.
April 1970, Acta medica Scandinavica,
K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO
Plasma proinsulin-like material in insulin treated diabetics.
November 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO
Serum insulin-like activity in untreated diabetics.
January 1962, Diabetes,
K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO
Plasma insulin response following intravenous glucose in gestational diabetics.
November 1977, Archiv fur Gynakologie,
K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO
[THE BEHAVIOR OF THE INSULIN ACTIVITY OF THE BLOOD AFTER ORAL GLUCOSE LOADING IN SUBJECTS WITH NORMAL METABOLISM AND IN DIABETICS].
January 1963, Rassegna di fisiopatologia clinica e terapeutica,
K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO
[Behavior of insulin-like activity in juvenile diabetics].
September 1966, Helvetica paediatrica acta,
K YAMADA, and T KOIDE, and K AOYAMA, and T HISANO
Plasma fibrinopeptide A levels during insulin-induced plasma glucose falls in diabetics.
November 1987, Diabetes research and clinical practice,
Copied contents to your clipboard!